BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15746435)

  • 1. Matrix metalloproteinase-9 modulation by resident arterial cells is responsible for injury-induced accelerated atherosclerotic plaque development in apolipoprotein E-deficient mice.
    Choi ET; Collins ET; Marine LA; Uberti MG; Uchida H; Leidenfrost JE; Khan MF; Boc KP; Abendschein DR; Parks WC
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1020-5. PubMed ID: 15746435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of MMP-2 deficiency on atherosclerotic lesion formation in apoE-deficient mice.
    Kuzuya M; Nakamura K; Sasaki T; Cheng XW; Itohara S; Iguchi A
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1120-5. PubMed ID: 16556856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smooth muscle cells healing atherosclerotic plaque disruptions are of local, not blood, origin in apolipoprotein E knockout mice.
    Bentzon JF; Sondergaard CS; Kassem M; Falk E
    Circulation; 2007 Oct; 116(18):2053-61. PubMed ID: 17938286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis.
    de Nooijer R; Verkleij CJ; von der Thüsen JH; Jukema JW; van der Wall EE; van Berkel TJ; Baker AH; Biessen EA
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):340-6. PubMed ID: 16306430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth.
    Luttun A; Lutgens E; Manderveld A; Maris K; Collen D; Carmeliet P; Moons L
    Circulation; 2004 Mar; 109(11):1408-14. PubMed ID: 14993123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries.
    Johnson JL; George SJ; Newby AC; Jackson CL
    Proc Natl Acad Sci U S A; 2005 Oct; 102(43):15575-80. PubMed ID: 16221765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice.
    Bea F; Kreuzer J; Preusch M; Schaab S; Isermann B; Rosenfeld ME; Katus H; Blessing E
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2787-92. PubMed ID: 16990551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques.
    Deguchi JO; Aikawa E; Libby P; Vachon JR; Inada M; Krane SM; Whittaker P; Aikawa M
    Circulation; 2005 Oct; 112(17):2708-15. PubMed ID: 16230484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of platelet P-selectin in the response to arterial injury in apolipoprotein-E-deficient mice.
    Manka D; Forlow SB; Sanders JM; Hurwitz D; Bennett DK; Green SA; Ley K; Sarembock IJ
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1124-9. PubMed ID: 15072990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compensatory vascular remodeling during atherosclerotic lesion growth depends on matrix metalloproteinase-9 activity.
    Lessner SM; Martinson DE; Galis ZS
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2123-9. PubMed ID: 15308548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
    Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
    Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice.
    Bengtsson E; To F; Håkansson K; Grubb A; Brånén L; Nilsson J; Jovinge S
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2151-6. PubMed ID: 16051881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrauterine exposure to maternal atherosclerotic risk factors increases the susceptibility to atherosclerosis in adult life.
    Alkemade FE; Gittenberger-de Groot AC; Schiel AE; VanMunsteren JC; Hogers B; van Vliet LS; Poelmann RE; Havekes LM; Willems van Dijk K; DeRuiter MC
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2228-35. PubMed ID: 17656671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development.
    Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis.
    Johnson JL; Baker AH; Oka K; Chan L; Newby AC; Jackson CL; George SJ
    Circulation; 2006 May; 113(20):2435-44. PubMed ID: 16702468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerosis in mice is not affected by a reduction in tissue factor expression.
    Tilley RE; Pedersen B; Pawlinski R; Sato Y; Erlich JH; Shen Y; Day S; Huang Y; Eitzman DT; Boisvert WA; Curtiss LK; Fay WP; Mackman N
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):555-62. PubMed ID: 16385085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis.
    Borst O; Schaub M; Walker B; Schmid E; Münzer P; Voelkl J; Alesutan I; Rodríguez JM; Vogel S; Schoenberger T; Metzger K; Rath D; Umbach A; Kuhl D; Müller II; Seizer P; Geisler T; Gawaz M; Lang F
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):547-57. PubMed ID: 25614279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: Role of downregulation of CD40 and MMP-9 expression.
    Liu G; Wang B; Zhang J; Jiang H; Liu F
    J Ethnopharmacol; 2009 Nov; 126(2):350-4. PubMed ID: 19703533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
    Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C
    Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of bone marrow-derived mononuclear cells in ischemic apolipoprotein E-knockout mice accelerates atherosclerosis without altering plaque composition.
    Silvestre JS; Gojova A; Brun V; Potteaux S; Esposito B; Duriez M; Clergue M; Le Ricousse-Roussanne S; Barateau V; Merval R; Groux H; Tobelem G; Levy B; Tedgui A; Mallat Z
    Circulation; 2003 Dec; 108(23):2839-42. PubMed ID: 14656923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.